MedTrace Logo

ACT-GEN (Adherence And Care Tracking In GENetic Cancer Syndromes)

NCT07565467 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2026-08-24

No results posted yet for this study

Summary

To help people with high-risk cancer variants to follow cancer surveillance guidelines and lower their risk of developing the disease.

Conditions

  • ACT-GEN
  • Genetic Cancer Syndromes

Interventions

OTHER

Standard of care

Standard of Care, no efforts will be made toward any of the study objectives

OTHER

Interviews

Up to three interviews may be conducted per participant, and they may take place remotely via a secure videoconferencing service to limit disruptions to the participants schedule as well as any financial burden associated with travel.

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Jose Rauh-Hain, MD · M.D. Anderson Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-10-08
Primary Completion
2031-03-01
Completion
2033-03-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07565467 on ClinicalTrials.gov